Connection

Mark Kindy to Enzyme-Linked Immunosorbent Assay

This is a "connection" page, showing publications Mark Kindy has written about Enzyme-Linked Immunosorbent Assay.
Connection Strength

0.338
  1. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis. 2012; 29(4):827-40.
    View in: PubMed
    Score: 0.086
  2. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
    View in: PubMed
    Score: 0.080
  3. Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res. 2008 Oct 31; 1238:143-53.
    View in: PubMed
    Score: 0.068
  4. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine. 2000 Sep; 12(9):1337-47.
    View in: PubMed
    Score: 0.039
  5. The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Mol Immunol. 2017 01; 81:59-66.
    View in: PubMed
    Score: 0.030
  6. Enzyme-linked immunosorbent assay for an octapeptide based on a genetically engineered fusion protein. Anal Chem. 1993 May 01; 65(9):1147-51.
    View in: PubMed
    Score: 0.023
  7. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci Res. 2003 Apr; 45(4):437-45.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.